Thiazide Diuretics Market size is anticipated to reach USD 234 Million by the end of 2036, growing at a CAGR of 7% during the forecast period, i.e., 2024-2036. In the year 2023, the Industry size of thiazide diuretics was over USD 104 Million. The increasing prevalence of hypertension drives the demand for thiazide diuretics. These medications effectively reduce blood pressure by eliminating excess fluid and sodium, making them a primary choice in managing hypertension and its associated risks. With a systolic blood pressure of more than 130 mmHg or a diastolic blood pressure of more than 80 mmHg, or with hypertension medication, over half of adults (48.1%, 119.9 million) have hypertension. Approximately 1 in 4 persons with hypertension (22.5 percent, 27.0 million) have their hypertension under control.
Further, the predicted prevalence of hypertension at the CCG level varies from 16% to 33.8%. Hypertension in general practitioner practices falls between 18.8% to 31%, with the top and worst 10% of practices excluded.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
7% |
|
Base Year Market Size (2023) |
USD 104 Million |
|
Forecast Year Market Size (2036) |
USD 234 Million |
|
Regional Scope |
|
Application (Hypertension, Cardiovascular Disorder, Hepatic Disorders, Kidney Disorders)
The hypertension segment is estimated to account for 48% of the global thiazide diuretics market during the forecast period. The rise in the number of hypertension drugs delivered through retail pharmacies and the rise in the number of retail pharmacies in highly developed countries, create opportunities. Further, the sedentary lifestyle adopted by the population, has resulted in cardiovascular diseases, providing opportunities for the segment’s growth.
Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
The retail pharmacies segment in the thiazide diuretics market is expected to hold a major revenue share. The retail pharmacies segment has undergone a technological revolution that has fuelled expansion and improved client satisfaction. Prescription filling procedures are made easier by pharmacy automation systems, clients can get prescriptions online, and telemedicine services enable remote medication delivery and consultation. In addition to increasing the effectiveness of retail pharmacies, these technological advancements draw in more clients, which helps the industry grow.
Our in-depth analysis of the global market includes the following segments:
|
Application |
|
|
Distribution Channel |
|
North American Market Forecast
North America thiazide diuretics market is poised to hold the largest revenue share, amounting to 45%. The market has seen consistent growth due to the prevalent cases of hypertension and related cardiovascular diseases. Thiazide diuretics, such as hydrochlorothiazide (HCTZ) and chlorthalidone, have been among the primary choices for managing hypertension in the region. Factors contributing to this market growth include a high incidence of hypertension among the population, lifestyle-related health issues, and an aging demographic.
APAC Market Statistics
The Asia Pacific region represents a significant and growing market for thiazide diuretics. With a rising prevalence of hypertension and related cardiovascular diseases across countries like China, India, Japan, and others, the demand for effective antihypertensive medications like thiazide diuretics is steadily increasing. Factors such as lifestyle changes, urbanization, and an aging population contribute to this growth.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?